This Phase 2 trial tested a drug called LEVI-04 in 518 adults with knee osteoarthritis. The drug is designed to block pain signals. Researchers measured pain changes using a standard knee pain scale. The goal is to see if LEVI-04 can safely reduce pain and improve daily function.
Phase: PHASE2 • Sponsor: Levicept • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC